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Abstract 
Objective: Post-traumatic stress disorder (PTSD) involves excessive retrieval of traumatic 
memories. Glucocorticoids impair declarative memory retrieval. This preliminary study 
examined the effect of acute hydrocortisone administration on brain activation in individuals 
with earthquake-related PTSD compared with earthquake-exposed healthy individuals, 
during retrieval of traumatic memories.  
Method: Participants exposed to earthquakes with (n=11) and without PTSD (n=11) 
underwent two fMRI scans, one-week apart, in a double-blind, placebo-controlled, counter-
balanced design. On one occasion they received oral hydrocortisone (20mg), and on the 
other, placebo, one hour before scanning. Symptom provocation involved script-driven 
imagery (traumatic and neutral scripts) and measures of self-reported anxiety.  
Results: Arterial spin labelling showed that both PTSD and trauma-exposed controls had 
significantly reduced cerebral blood flow in response to retrieval of traumatic versus neutral 
memories in the right hippocampus, parahippocampal gyrus, calcarine sulcus, middle and 
superior temporal gyrus, posterior cingulate, heschls gyrus, inferior parietal lobule, angular 
gyrus, middle occipital gyrus, supramarginal gyrus, lingual gyrus and cuneus, and the left 
prefrontal cortex. Hydrocortisone resulted in non-significant trends of increasing subjective 
distress and reduced regional cerebral blood flow in the left inferior frontal gyrus, left 
anterior cingulate gyrus, middle temporal gyrus, cerebellum, post central gyrus  and right 
frontal pole, during the trauma script.  
Conclusion: Findings do not fit with some aspects of the accepted neurocircuitry model of 
PTSD, i.e., failure of the medial prefrontal cortex to quieten hyperresponsive amygdala 
activity, and the potential therapeutic benefits of hydrocortisone. They do, however, provide 
further evidence that exposure to earthquake trauma, regardless of whether PTSD eventuates, 
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impacts on brain activity and highlights the importance of inclusion of trauma-exposed 
comparisons in studies of PTSD.  
Key Words:   PTSD, Trauma Exposure, Neuroimaging   
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Introduction 
Post-traumatic stress disorder (PTSD) is a debilitating condition which develops in a 
significant minority of people after exposure to a potentially traumatic event. Intrusive 
memories are one of the hallmarks of PTSD, reflecting excessive consolidation and 
subsequent retrieval of the traumatic memory, which retains its vividness and power to evoke 
distress (Brewin et al., 2010). An understanding of the neurobiology behind these intrusive 
memories is a crucial step in the development of effective interventions for PTSD.  
Script-driven imagery involves presentation of autobiographical scripts of traumatic 
events in order to examine brain activity while traumatic memories are invoked (Bremner et 
al., 1999). Although mixed, the most common findings using this technique in PTSD have 
been reduced activation of the anterior cingulate gyrus (ACC) (Lanius et al., 2001; Lanius et 
al., 2003), medial frontal gyrus (Lindauer et al., 2004; Shin et al., 2004), and hippocampus 
(Bremner et al., 1999). Patients with PTSD also show a negative correlation between 
amygdala and medial prefrontal cortex (mPFC) activation in response to fearful versus happy 
faces, suggesting a disconnect in the normal modulation of the amygdala by the mPFC (Shin 
et al., 2005). This literature supports the neuroanatomical model of PTSD as a failure of 
mPFC/ACC networks to regulate amygdala activity, resulting in amygdala hyper-reactivity to 
threat (Shin et al., 2006).  
Abnormalities in glucocorticoid regulation have been demonstrated in PTSD, 
although findings are inconsistent. These include generally low endogenous cortisol levels 
(Yehuda et al., 1996; Bremner et al., 2007) (although recent meta-analysis suggests only in 
certain subgroups and circumstances (Meewisse et al., 2007)), enhanced glucocorticoid 
sensitivity (Yehuda, 2001), and that reduced cortisol excretion in response to a traumatic 
event is associated with a higher risk of developing PTSD (Yehuda et al., 1998). Release of 
cortisol facilitates reinstatement of physiologic homeostasis and contains the sympathetic 
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nervous system response to stress, and conversely, reduced cortisol may impede this, 
resulting in adrenaline facilitating consolidation of threat memory (McGaugh and 
Roozendaal, 2002). In support of this, a recent meta-analysis reported that early 
administration of hydrocortisone after a traumatic event is effective in prevention of PTSD 
(Sijbrandij et al., 2015).  
Once PTSD is established, the efficacy of current treatments is limited (Watts et al., 
2013) and alternative treatments such as glucocorticoids may offer important therapeutic 
advances. In this context, it is notable that acute elevation of glucocorticoid levels can 
temporarily inhibit both retrieval of episodic memory (de Quervain et al., 2000; de Quervain 
et al., 2003), and of particular relevance, retrieval of perceptually primed material in a 
“traumatic” context (Holz et al., 2014). It has therefore been suggested that corticosteroids 
may diminish the retrieval of traumatic memories and promote extinction and inhibitory fear 
learning (Sijbrandij et al., 2015). This has been examined clinically in a pilot study of three 
patients with chronic PTSD, given low-dose cortisol (10 mg per day) for one month, which 
reported significant cortisol-related reductions in symptoms of traumatic memories (Aerni et 
al., 2004). Glucocorticoid administration has also been shown to enhance the efficacy of 
prolonged exposure treatment for PTSD (Yehuda et al., 2015).  
Only one previous study has examined the effect of cortisol administration on brain 
activation in PTSD. Yehuda et al. used Positron Emission Tomography (PET) during resting 
state to investigate hydrocortisone administration (17.5mg) versus placebo in male combat 
veterans with (n=16) or without (n=16) PTSD (Yehuda et al., 2009). The overall effect of 
hydrocortisone administration was to restore a normal inverse association between the ACC 
and amygdala in the PTSD group.   
The current study uses a similar approach to Yehuda et al. (2009) of examining the 
short-term effects of administration of hydrocortisone on brain activation as assessed by 
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fMRI. Essentially, the study aims to investigate some aspects of the mechanism of action of 
hydrocortisone by determining its effect in the specific context of trauma imagery. We also 
aim to examine this effect between groups -  in individuals with PTSD and a group of 
similarly trauma-exposed, healthy controls (TEC).  
The sample in this study is unique in that all participants (PTSD patients and TEC) 
experienced similar traumatic events. Between the years of 2010 and 2012, a series of four 
major earthquakes struck the city of Christchurch, New Zealand resulting in 185 deaths, 
substantial damage to the central city, and over 10,000 subsequent aftershocks (Ardagh et al., 
2012).  
Key hypotheses in this study were that in response to trauma scripts (compared with 
neutral scripts), patients with PTSD versus TECs would have greater anxiety and would show 
reduced mPFC and greater amygdala activation. In addition, these subjective and imaging 
effects would be attenuated by hydrocortisone.  
 
Methods 
Participants 
PTSD Participants: Participants recruited into the study were those referred to a specialist 
outpatient, treatment programme for earthquake-related anxiety in Christchurch, New 
Zealand. All PTSD participants were aged over 18 years and were diagnosed with PTSD by 
an experienced clinician according to DSM-IV criteria (American Psychiatric Association, 
1994). Diagnosis at the time of neuroimaging was confirmed by a second clinician using the 
Clinician Administered PTSD Scale (CAPS) (Blake et al., 1995). PTSD symptomatology was 
directly related to the Canterbury earthquakes. Exclusion criteria were: presence of 
contraindications to glucocorticoid therapy (e.g., tuberculosis, gastric and duodenal ulcers, 
Cushing’s disease, hypertension, pregnancy), significant physical disease, current 
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topical/inhaled glucocorticoid therapy, current psychosis, bipolar disorder, severe depressive 
disorder (total score ≥ 17 on Hamilton Depression Rating Scale-17 Item; HAM-D-17) or 
substance-related disorder (screened using the Mini International Neuropsychiatric Interview 
(MINI) (Sheehan et al., 1998)), severe personality disorder, severe cognitive impairment or 
organic psychiatric disorder, random blood glucose measurement above normal range, or any 
contraindication to fMRI. In relation to antidepressant medication use, seven PTSD patients 
were on no medication, two were prescribed selective serotonin reuptake inhibitors (SSRIs), 
one a serotonin-noradrenaline reuptake inhibitor (SNRI), and one a tricyclic antidepressant 
(TCA).   
 
Trauma-Exposed Healthy Controls: The TEC group consisted of volunteers over 18 years old 
from the general population in Christchurch who had experienced the earthquakes. They were 
recruited through flyers posted in public places. These participants fulfilled criterion A1 for 
PTSD from DSM-IV in relation to the earthquakes (i.e., experienced the earthquakes as life-
threatening) but did not fulfil diagnostic criteria for PTSD or any other mental disorder 
(screened with the MINI). Exclusion criteria were identical to the PTSD group. PTSD and 
TEC groups were matched for age, gender, and where possible, handedness. All participants 
were fluent in English. Patients and TECs were recruited simultaneously, and at a similar 
rate, between November 2013 and February 2016.  
 
Study Design 
This was an fMRI study of participants exposed to earthquake-related trauma; one group with 
and the other group without PTSD. Each participant underwent two fMRI scans at the same 
time of day, one week apart, in a double-blind, placebo-controlled, cross-over design. On one 
occasion they received hydrocortisone (20mg), and on the other, a placebo, one hour before 
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scanning and script-driven imagery. This dose was chosen to be in the range of that used in 
the only previous study of brain activation in individuals with PTSD (Yehuda et al., 2009). 
The identity of the drug/placebo (lactose) was concealed by being encapsulated, and 
therefore, looked identical. This study was approved by the National Health and Disability 
Ethics Committee (Southern Branch; 12/STH/69) and all participants gave informed written 
consent. 
 
Scripts  
At least one day prior to the first fMRI scan, all participants provided an autobiographical 
description of their most traumatic experience related to the earthquakes and of a neutral life 
event. The script-driven imagery methodology used was adapted from previous neuroimaging 
studies (Shin et al., 1999; Lanius et al., 2001; Shin et al., 2004). Participants were asked to 
think carefully about the events, to give a detailed narrative of what happened and 
encouraged to include a description of bodily senses experienced during the trauma. These 
narratives were converted by a Research Nurse (LW) into scripts written in the first person 
and present tense that were able to be presented onto the fMRI computer screen. The same 
number of words were used for the neutral and traumatic conditions (70 words). In addition 
to the scripts, three key words were agreed on between the participant and Research Nurse 
that represented the neutral and traumatic scripts for use during the Blood Oxygen Dependent 
(BOLD) measurements (see below).    
 
Procedure  
One hour prior to each fMRI scan, participants provided the first of three saliva swabs as a 
baseline measure of salivary cortisol. Immediately following this, they took either 
hydrocortisone or placebo. During this hour, they were familiarised with the Subjective Units 
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of Distress Scale (SUDS) which was used as a measure of state anxiety or distress, with 0 = 
‘completely relaxed’ and 10 = ‘highest anxiety/distress ever felt’. Immediately before the 
fMRI scan began, participants provided their first SUDS rating to the Research Nurse and 
their second saliva swab.  
Each scanning session included the following: a high resolution T1-weighted scan, T2 
and T2 FLAIR acquisitions (to exclude incidental clinical findings), a resting state functional 
connectivity acquisition, two cerebral perfusion acquisitions, and one functional BOLD 
acquisition. Perfusion scanning occurred after the T1 and resting state acquisition. During the 
first perfusion run (6:46), participants were presented with their neutral script. Participants 
were presented with their traumatic script during the second perfusion run. Order of script 
presentations was fixed for each participant. During the presentation of these scripts, 
participants were instructed to imagine being present at the event, and to recall emotions and 
bodily sensations experienced at the time of them. At the end of each script presentation, 
participants were asked to provide a current SUDS rating. After acquiring the T2 and T2-
weighted images, a 10-minute BOLD fMRI run was acquired. During this, participants were 
asked to read alternating presentations of the three key words for each script (neutral and 
traumatic) for periods of 30 seconds, for a total of 10 minutes, to allow measurement of 
BOLD signal. At the end of the fMRI scanning session, participants provided their final 
saliva swab sample and SUDS rating.  
Details about image acquisition, structural pre-processing and analysis, ASL pre-
processing and analysis, and functional pre-processing and analysis are provided as online 
supplementary material see Supplemental Material A. 
 
Cortisol Analysis 
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Cortisol data was collected using Salivette tubes (Sarstedt). Participants first placed a cotton 
swab provided in each Salivette tube in his or her mouth and gently chewed on it for about 
one minute. The swab was then placed back in the tube. Tubes were kept at -20°C until 
analysis. Briefly thawed saliva (250µL) was extracted with 1.0 mL of dichloromethane and 
500uL portions evaporated to dryness. Dried extracts were reconstituted in 125µL of buffer 
and analysed for cortisol by enzyme-linked immunosorbent assay using a series of standards 
from 0 to 280 nmol/L (as described in Lewis et al. (1992)). Sample sets from each participant 
were analysed in the same batch to avoid inter-assay variation and the intra-assay variation 
was 7.6%. 
 
Statistical Analysis (non-imaging) 
Statistical analyses of demographic, clinical and cortisol data were conducted using SPSS 
version 22-x for Windows (IBM Coorporation, 2013). To assess demographic and clinical 
data, χ2 tests or independent samples t-tests were used, with group (PTSD vs TEC) as the 
between-participants factor. For cortisol and SUDS data, repeated measures analysis of 
variance (ANOVA) was used with group (PTSD vs. TEC) as the between-participants factor 
and drug (hydrocortisone vs. placebo) and time (cortisol: baseline, pre-scan and post-scan; 
SUDS: baseline, pre-neutral script, post-neutral script, post-trauma script, post-scan) as the 
within-participant factors.  
 
Results 
Thirteen patients with PTSD and 12 TECs consented to and commenced study procedures. 
One patient with PTSD dropped out of the study as they refused a follow-up session due to 
distress associated with the scanning procedure. Two participants (one PTSD and one TEC) 
were excluded from all imaging analyses; one had a major frontal artefact and with the other 
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participant, there were technical issues with the scanner. Thus, 11 patients with PTSD and 11 
TEC participants were included. Groups did not differ in age, gender, years of education or 
date of testing (number of months after February 2011 earthquake) (see Table 1). Total CAPS 
score in the PTSD group was 60.2, representing moderately severe PTSD, and total HAM-D 
score was 10.6, representing mild depression.  
 
Insert Table 1 Approx Here 
 
Subjective Anxiety Ratings 
Repeated measures ANOVA of SUDS ratings showed a significant effect of Group (F=11.1, 
p=0.003), with ratings being significantly higher in the PTSD group compared with the TEC 
group (see Figure 1). In both groups, subjective anxiety peaked after presentation of the 
trauma script (T4), as reflected in a significant effect of Time (F=8.1, p<0.0001), but the peak 
in subjective anxiety was much more pronounced in the PTSD group compared with the TEC 
group, as reflected by a significant Time by Group interaction (F=4.2, p=0.004). Repeated 
measures ANOVA showed a trend towards an effect for Drug (F=3.5, p=0.08) and for a Drug 
x Group interaction (F=3.7, p=0.07), with the hydrocortisone condition related to greater 
SUDS ratings in the PTSD compared with control group.  
 
Insert Figure 1 Approx Here 
 
Imaging Results 
Missing and excluded data 
One participant (PTSD group) was excluded from the ASL analyses as the trauma script was 
not displayed at baseline, and another (TEC group) was excluded from fMRI analyses, as 
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functional images were not acquired at follow-up. Thus, group numbers were as follows for 
imaging analyses: structural analyses: PTSD patients n=11, controls n=11; ASL analyses: 
PTSD patients n=10, TEC n=11; fMRI analyses: PTSD patients n=11, TEC n=10.  
 
Structural Analyses 
Whole brain analyses, controlling for age and gender, revealed no significant differences 
between the PTSD (n=11) and TEC (n=11) groups. 
 
ASL Analyses 
Whole brain analyses revealed a significant main effect of Condition (trauma vs neutral; 
FDR-corrected p<0.001). Regional blood flow was significantly reduced in the trauma 
condition versus neutral condition in the following areas: right hippocampus, 
parahippocampal gyrus, calcarine sulcus, middle and superior temporal gyrus, posterior 
cingulate, heschls gyrus, inferior parietal lobule, angular gyrus, middle occipital gyrus, 
supramarginal gyrus, lingual gyrus and cuneus and the left middle and inferior frontal gyrus 
(pars triangularis) (see Table 2 and Figure 2). No significant main effects of Group or Drug 
were found, nor were there any significant interactions between Group and Drug, or Group, 
Condition and Drug.  
 
Insert Table 2 and Figure 2 Approx Here 
 
Prior to correcting for multiple comparisons, a significant Condition x Drug interaction was 
found (see Table 3 and Figure 3). Regional blood flow in the left inferior frontal gyrus, left 
ACC, left middle temporal gyrus, left cerebellum, right frontal pole and left post central 
gyrus was significantly reduced after hydrocortisone administration compared with placebo 
administration during the trauma script presentation. With the neutral script, the regional 
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blood flow was unchanged between hydrocortisone and placebo. This interaction did not 
remain after correction for multiple comparisons.  
 
Insert Table 3 and Figure 3 Approx Here 
 
BOLD Functional Analyses 
Whole brain analyses, controlling for age and gender, revealed no significant main effects of 
Condition (trauma vs. neutral words), Group or Drug, as well as no significant interactions.  
 
Cortisol Levels 
Baseline cortisol levels were not significantly different between PTSD and TEC groups 
(t=0.06, p=1.0). Repeated measures ANOVA showed significant effects of Drug (F=71.0, 
p<0.0001), with cortisol levels being significantly higher when hydrocortisone was 
administered compared with when the placebo was administered (see Figure 4). A significant 
effect of Time (F=23.2, p<0.0001) reflected peak cortisol levels that occurred one hour after 
hydrocortisone administration (i.e., immediately prior to imaging session; see Figure 4). No 
effect of Group (F=2.4, p=0.14) was found, nor was there a significant interaction between 
Drug and Group (F=3.1, p=0.09).  
 
 
Discussion 
This is the first neuroimaging study to investigate the effect of acute glucocorticoid 
administration on brain activity during symptom provocation using script-driven imagery, in 
patients with PTSD and TECs. Key hypotheses were that in response to trauma scripts 
(compared with the neutral scripts), patients with PTSD (compared with TECs) would have 
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greater anxiety and would show reduced mPFC activation and greater amygdala activation, 
and that these subjective and imaging effects would be attenuated by hydrocortisone 
administration.  
 
Trauma Scripts Resulted in Increased Anxiety 
Both the PTSD and TEC groups reported increased anxiety in response to trauma compared 
with neutral scripts. As expected, patients with PTSD experienced the script-driven imagery 
procedure as subjectively more anxiety-provoking (SUDS) than the TEC group. This has 
been a consistent finding in neuroimaging studies using script-driven imagery (Lindauer et 
al., 2004; Lanius et al., 2007).  
 
Cerebral Blood Flow Changes in Response to Trauma Scripts 
In both groups, recollection and imagery of traumatic versus neutral personal events was 
associated with significantly reduced cerebral blood flow in the right hippocampus, 
parahippocampal gyrus, calcarine sulcus, middle and superior temporal gyrus, posterior 
cingulate, heschls gyrus, inferior parietal lobule, angular gyrus, middle occipital gyrus, 
supramarginal gyrus, lingual gyrus and cuneus, and the left inferior and middle frontal gyri. 
These findings are consistent with previous reports of decreased activation of the ACC 
(Lanius et al., 2001; Lanius et al., 2003), the medial frontal gyrus (Lindauer et al., 2004; Shin 
et al., 2004), and the hippocampus (Bremner et al., 1999) in patients with PTSD. It has been 
suggested that reduced activity in these brain regions may impair the extinction of fear and 
thereby play a role in the development or maintenance of symptoms of PTSD (VanElzakker 
et al., 2014).   
Although the neurocircuitry model of PTSD described above (Hayes et al., 2012) 
proposes amygdala hyper-reactivity, we did not find amygdala activation in response to 
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traumatic (vs. neutral) scripts in either group. This surprising lack of amygdala activation has 
however been reported previously by studies of similar design using script-driven recall 
(Lanius et al., 2001; Lindauer et al., 2004).  
 We had hypothesised that in reponse to trauma scripts, the PTSD group would show 
greater amygdala activation and reduced mPFC activation compared with the TEC group.  
Overall, we found no differences in cerebral blood flow during script-driven imagery 
between PTSD and TEC groups, which was an unexpected and notable finding. This finding, 
however, was consistent with the most comparable previous study using SPECT in 30 police 
officers with PTSD compared with trauma-exposed controls (Lindauer et al., 2004). Recent 
meta-analyses have also reported that differences in amygdala activation are not observed 
when comparisons are between patients with PTSD and TECs  (rather than non-trauma-
exposed controls) (Patel et al., 2012; O'Doherty et al., 2015). Our finding of no difference in 
mPFC activation between groups is, however, different from that reported by the Lindauer 
study (Lindauer et al., 2004) and meta-analyses of functional (Hayes et al., 2012; Patel et al., 
2012; Stark et al., 2015) and structural (O'Doherty et al., 2015) brain imaging studies which 
provide evidence for decreased activity and volume in the mPFC, left inferior cortex and 
ACC in PTSD compared with trauma-exposed and non-exposed controls.  
 It may be that differences in findings is explained by the form in which the trauma-
related information is presented. Some previous studies have presented trauma-related 
pictures, some have presented audiotaped scripts (Lindauer et al., 2004; Lanius et al., 2007), 
while in the current study the trauma scripts were presented visually. Interestingly, studies 
which have reported amygdala hyper-responsivity have typically used external cues (such as 
pictures) suggesting that heightened amygdala activation in these studies is related more to 
the processing of external rather than internal stimuli (Reiman et al., 1997; Phan et al., 2002). 
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The results may also be different partly because of the slightly different imaging modality 
(SPECT vs BOLD).  
The finding of no significant difference in brain activation between the groups 
emphasises the importance of including TEC comparisons, which has been an area of 
increasing interest. Meta-analyses have reported that when patients with PTSD are compared 
only with TECs  (rather than including non-trauma-exposed controls), there was only 
differential involvement between the groups in the basal ganglia (Stark et al., 2015). This 
suggests that the experience of trauma (whether it leads to symptoms consistent with PTSD 
or not) may have lasting effects on the brain, which has been supported by many recent 
imaging studies (Lu et al., 2017; Chen et al., 2018; Malhi et al., 2019). Of note, a long-term 
(41 months) study of functional connectivity in TECs exposed to earthquakes in China, 
compared with non-trauma-exposed controls, reported greater grey matter density in 
prefrontal-limbic systems (dorsal ACC, medial PFC, amygdala and hippocampus (Li et al., 
2017). Similarly, a study following up soldiers exposed to combat reported persisting brain 
connectivity changes in the mid-brain 1.5 years after combat-exposure (van Wingen et al., 
2012).  
 
Effect of Hydrocortisone 
Hydrocortisone significantly elevated cortisol levels over the course of the brain imaging 
session in both groups. It also resulted in a trend towards increasing subjective measures of 
anxiety in the PTSD group compared with the TEC group. This was counter to our hypothesis 
and is an interesting finding, but is tempered by the fact that this was only seen at statistical 
trend level. Although previous studies have been of small sample size, they have suggested 
that hydrocortisone in PTSD patients has therapeutic effects in reducing re-experiencing 
symptoms (Aerni et al., 2004), diminishing avoidance and numbing symptoms in response to 
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script-driven imagery (Suris et al., 2010), reducing drop-out rates, and improving the 
outcome of prolonged exposure treatment (Yehuda et al., 2010; Yehuda et al., 2015).  
We had hypothesised that hydrocortisone would attenuate the predicted amygdala 
hyperactivation and/or mPFC hypoactivation in response to the trauma scripts. In a previous 
study using PET imaging in older veterans, hydrocortisone restored the normal inverse 
relationship between activity of the ACC and amygdala in the PTSD group (Yehuda et al., 
2009). As described above, we found reduced mPFC activation (but not amygdala hyper-
activation) in response to the anxiety-provoking trauma scripts, but also, that there was no 
significant difference between groups. The effect of hydrocortisone was also not significantly 
different between groups. Hydrocortisone, in both groups, resulted in a reduction in regional 
cerebral blood flow in the left inferior frontal gyrus, left ACC, left middle temporal gyrus, 
left cerebellum, right frontal pole and left post central gyrus, but only during the trauma script 
presentation. Neurocircuitry models would suggest that reduced activation in these regions 
results in decreased regulation of mPFC/ACC networks to regulate amygdala activity, 
resulting in hyper-reactivity to threat (Shin et al., 2006). These findings are not consistent 
with the glucocorticoid hypothesis of PTSD described earlier. A possible explanation for the 
reduction in cerebral blood flow in response to hydrocortisone may reflect findings from 
previous studies in non-trauma-exposed healthy controls, which reported that hydrocortisone 
impairs declarative memory retrieval processes and reduces cerebral blood flow in the right 
posterior medial temporal lobe, cerebellum and left visual cortex (de Quervain et al., 2003). 
A recent systematic review of studies of PTSD in the context of ongoing threat (Fragkaki et 
al., 2016) reported that, although inconsistent, there was a pattern of increased cortisol being 
more pronounced in PTSD patients than TECs, which may explain our finding of a trend 
towards hydrocortisone increasing anxiety in the PTSD group. It is important to note that 
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these findings of the effects of hydrocortisone on cerebral blood flow were equivocal in that 
they did not remain after correction for multiple comparisons.   
One of the possible reasons for a lack of effect of hydrocortisone on measures of brain 
activation is the dose used in this study (20mg). This is a relatively low dose. Doses of 20mg 
twice per day have often been used to attempt to mimic the cortisol levels seen in depression 
(Young et al., 1999). Behavioural data (SUDS) did show a difference following 
administration of hydrocortisone at a trend level. This is suggestive of, but not proof of, at 
least some effect of this dose of hydrocortisone. Another related issue is the pharmacokinetics 
of hydrocortisone. We timed the scan to occur around the time of peak levels (one hour after 
dosing). As can be seen from Figure 1, levels were highest in the sample immediately before 
the scan (T2) but were still very significantly raised at the end of scanning (T3). The 
pharmacokinetics of hydrocortisone are also likely to be relevant for treatment effects. The 
only preliminary treatment study administered 10mg daily for one month. At this point it is 
clearly not known whether beneficial effects would be seen following higher doses for a 
shorter period of time or whether a constant elevation of cortisol levels, which for instance 
might be seen with twice daily dosing, would be more beneficial. This study suggests that a 
single relatively low dose does not have profound effects.  
 
Cerebral Blood Flow; ASL vs BOLD Analyses 
This study used both an ASL paradigm during prolonged trauma recollection and a BOLD 
approach which contrasted response to trauma-related words with neutral words. Use of 
hydrocortisone was the reason for selection of the ASL method in this study (Stewart et al., 
2014). The prolonged ASL paradigm showed differences between the traumatic and neutral 
script presentation. One previous study used a prolonged presentation of trauma-related 
stimuli but measured the BOLD response. Surprisingly, the BOLD response, which has been 
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most extensively used in previous studies, showed no differences between groups or between 
the traum- related and neutral words in the current study. It is possible that this may be 
explained by the order of the scanning sessions, with BOLD acquisition being performed 
after the cerebral perfusion acquisitions (i.e. after the neutral and trauma scripts). SUDs 
ratings indicated that after trauma scripts, both groups reported increased distress, and this is 
when the BOLD runs were acquired. There may, therefore, have been carry-over effects into 
this run.  
 
Unique Aspects and Strengths of this Study Design  
What sets the current study findings apart from the previous literature is the lack of 
differences in activation between the PTSD and TEC groups during symptom provocation. 
This suggests that it is exposure to earthquake-related trauma itself that impacts on brain 
activation when recollecting memories related to the traumatic memories, and that this is not 
specific for the diagnosis of PTSD. We have previously reported similar findings in terms of 
impacts of the earthquake exposure of emotion processing and neuropsychological 
functioning (Bell et al., 2017; Bell et al., 2018).  
There has been increasing interest in understanding PTSD under circumstances of 
ongoing threat, such as that occurring in this study with the ongoing exposure to aftershocks 
(over 10,000 in a 2 year period) and post-earthquake stressors (Fragkaki et al., 2016).  
Clinically, it could be hypothesised that this continued exposure could fuel symptomatology 
and have persisting impacts on brain neurobiology and neuroendocrinology, resulting in both 
groups being in a chronically hyperaroused state. Interestingly, however, the TECs although 
fulfilling criteria for exposure to a Criterion A event from DSM-IV definition of PTSD, did 
not report symptoms reaching threshold for other criteria (suggesting that levels of 
hyperarousal were not significant).  
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Both patient and TEC samples recruited in this study are different in several ways 
from those in previous studies. Importantly, both groups in this study experienced the same 
traumatic event. Many script-driven imagery studies have recruited PTSD and control 
samples who have experienced different types of trauma, including various traumatic events 
likely to occur to a police officer (Lindauer et al., 2004), samples with a combination of male 
combat veterans and female nurse veterans (Shin et al., 2004), or a combination of sexual 
abuse and motor vehicle accidents (Lanius et al., 2003). While previous studies have typically 
included control groups who have experienced similar trauma to PTSD groups, no specific 
measure of the control groups’ interpretation of the trauma has been included (with the 
exception of Lanius et al. (2003)). That is, TEC participants may have experienced a severe 
trauma but they may not have interpreted the trauma as life-threatening or traumatising. In 
the current study, the trauma-exposed control group experienced the earthquake trauma as 
traumatising and life-threatening, and fulfilled criteria for exposure to a DSM-IV PTSD 
Criterion A event. Both groups had also been exposed to the post-earthquake environment 
and the prolonged series of aftershocks over at least a 2 to 3 year period. In addition, many 
previous studies have examined patients with longstanding PTSD related often to wars or 
sexual abuse. The patients in this study had relatively recent onset PTSD from exposure to 
earthquakes a maximum of 4 years earlier. The time passed since the onset of the earthquakes 
was also similar between groups, as TEC participants took part in the study immediately after 
completion of an age- and gender-matched patient. Finally, individuals with PTSD in the 
current study had low levels of comorbidity due to the exclusion process. Many previous 
imaging studies have included PTSD samples with high levels of major depression and other 
psychiatric disorders, and thus, the possibility that their findings may be, in part, related to 
features of comorbid conditions may have complicated findings.  
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We suggest that the design of this study, and specifically, similarities between the two 
groups in terms of trauma exposure, low psychiatric comorbidity, and well-matched 
demographic characteristics, gives considerable weight to the findings and may explain the 
differences in our findings in comparison with the previous literature.  
 
Limitations 
The study was small and lack of positive results may relate to lack of power, and as such, 
these results can be considered only preliminary. However, previous brain imaging studies of 
PTSD using symptom provocation have reported significant findings with similar sample 
sizes to the current study (Bremner et al., 1999; Shin et al., 1999; Lanius et al., 2001; Lanius 
et al., 2003). This criticism is true to a lesser extent when considering the hydrocortisone 
compared with placebo comparison in which individuals were their own controls. There are 
also a number of other limitations of the current study. First, in order to determine whether 
exposure to earthquake trauma (not necessarily progression to PTSD) results in changes in 
brain activation, a control group consisting of non-exposed controls would have been 
required. This would have involved recruitment of a group of participants outside of the 
Canterbury region, which was not feasible in the current study. Second, although the TEC 
group did not have any mental disorder, we did not have a measure of a count of PTSD 
symptoms using, for example, the CAPS, which may have informed further description of 
this group. In addition, although the TEC group was exposed to a similar trauma as the PTSD 
group, and interpreted the trauma as life-threatening, a systematic measure of trauma 
exposure was not included in order to compare the extent of trauma exposure between 
groups. The Traumatic Exposure Severity Scale (TESS (Elal and Slade, 2005)), which was 
designed specifically to assess trauma severity to natural disasters, would have been a useful 
addition to this study in order to compare earthquake exposure severity between groups. 
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Third, four of the 11 PTSD participants were taking antidepressant medication, which was 
too small a number to comment on, although previous studies have suggested that that this 
may affect activation in the medial frontal gyrus but with little or no impact in other mPFC 
regions (Dahlgren et al., 2018). Fourth, research suggests that symptom provocation may 
result in two different brain activation patterns depending on whether the patient responds to 
trauma recollection and imagery with symptoms of hyperarousal or dissociation (Lanius et 
al., 2006). While anxiety was assessed throughout the symptom provocation procedure in the 
current study, dissociative responses were not. If the sample was heterogeneous in terms of 
having dissociative or hyperarousal responses to trauma recollection, this may have served to 
weaken any effects seen.  
 
Implications and Conclusions 
The preliminary study has considerable strengths, particularly the groups being well matched 
for trauma exposure. The findings do not fit with some aspects of the accepted neurocircuitry 
model of PTSD (i.e., failure of the mPFC to quieten hyperresponsive amygdala activity and 
the potential therapeutic benefits of hydrocortisone). The uniqueness of the setting of this 
study, with ongoing earthquake and aftershock exposure, may provide some explanation for 
this. The study suggests the importance of including a TEC group in studies of PTSD and the 
role of ongoing threat. In addition, findings provide further evidence that repeated exposure 
to earthquake trauma, regardless of whether PTSD eventuates from this exposure, impacts on 
brain activity. Individuals who cope well with stress related to traumatic events may still be 
affected from a neurobiological perspective, but become resilient through other pathways. 
Future neuroimaging studies involving longer-term follow-up (i.e., once aftershocks have 
ceased) of earthquake-exposed controls in comparison to non-exposed controls would be of 
use to elucidate brain areas involved in the stress and threat from earthquake exposure. 
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Table 1. Demographic and Clinical Characteristics of Post-traumatic Stress Disorder (PTSD; 
n=11) and Trauma-exposed Control (TEC; n=11) Groups 
 
 PTSD  TEC    
 Mean SD Mean SD T/χ2 P-value 
Age (years) 56.0 10.3 53.9 9.9 0.5 0.6a 
Gender (male:female) 6:5 - 6:5 - 0.0 1.0b 
Education (total years 
secondary and tertiary) 
6.7 3.1 8.5 2.9 -1.4 0.2a 
Handedness (right:left) 10:1 - 10:1 - - 1.0c 
Time since Earthquake 
(months) 
46.0 7.9 47.1 10.3 -0.3 0.8 
CAPS total score 60.2 25.2 - - - - 
HAM-D-17 total score 10.6 5.8 - - - - 
CAPS = Clinician Administered PTSD Scale, HAM-D-17 = Hamilton Depression Rating Scale 17 
items 
a Independent samples T-test 
b Pearson chi-squared test 
c Fisher’s exact test (no statistical value available) 
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Table 2. Cluster Sizes of Brain Regions from ASL that Showed Significant Differences 
between Trauma and Neutral Script Conditions in Post-traumatic Stress Disorder (PTSD; 
n=10) and Trauma-exposed Control (TEC; n=11) Groups 
Cluster size Brain region X Y Z Coordinates 
     
28186 
 
R. Hippocampus  33 -21 -17 
 
 
R. Parahippocampal Gyrus 18 -35 -12 
 
 
R. Calcarine Sulcus 17 65 12 
 R. Middle Temporal Gyrus 54 -9 -20 
  54 -42 3 
  51 -54 8 
  
 
65 -26 13 
 
 
R. Precuneus  14 -66 32 
 R. Superior Temporal Gyrus 47 -15 0 
  57 -39 18 
 
 
 62 -29 10 
 
 
R. Posterior Cingulate Cortex 6 -41 18 
 
 
R. Heshcls Gyrus 41 -23 8 
 R. Inferior Parietal Lobule 50 -56 48 
 
 
 56 -47 40 
 
 
R. Angular Gyrus 38 -68 41 
 
 
R. Middle Occipital Gyrus 45 -78 15 
 R. Supramarginal Gyrus 50 -32 39 
  62 -16 25 
 
 
R. Lingual Gyrus 9 -75 -3 
 R. Cuneus 13.5 -84 18 
     
1267 L. Inferior Frontal Gyrus -42 32 8 
  -38 27 21 
 
 
 -35 41 2 
 L. Middle Frontal Gyrus -30 44 18 
  -35 31 37 
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Table 3. Cluster Sizes of Brain Regions from ASL that Showed Significant Differences 
between Hydrocortisone and Placebo Conditions during Trauma Script Presentation in Post-
traumatic Stress Disorder (PTSD; n=10) and Trauma-exposed Control (TEC; n=11) Groups 
 
Cluster size Brain region 
X Y Z 
MNI Coordinates (mm) 
2323 L. Inferior Frontal Gyrus -49.5 13.5 12 
133 L. Anterior Cingulate Gyrus -7.5 21 30 
91 L. Middle Temporal Gyrus -63 -15 -9 
67 L. Cerebellum 1.5 -43.5 -13.5 
56 R. Frontal Pole 51 42 18 
43 L. Post Central Gyrus -54 -16.5 27 
 
 
X:  0 voxel space=right of image (90mm); 120 voxel space=left of image (-90mm) 
Y: 0 voxel space = back of brain (-126mm); 144=front of brain (90mm) 
Z: 0 voxel space = bottom of brain (-72mm); 120=top of brain (108mm) 
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Figure 1 
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Figure 1. Mean (SD) Subjective Units of Distress Scale (SUDS) score over time after 
administration of hydrocortisone or placebo in PTSD and Trauma-exposed healthy control 
(TEC) groups 
Note: T1 = baseline, T2 = pre-neutral script, T3 = post-neutral script, T4 = post-trauma script, T5 = 
end scan 
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Figure 2 
 
 
 
 
Figure 2. Regions of cerebral blood flow decrease in the traumatic versus neutral comparison 
in all participants (PTSD and TEC groups, cluster-wise FDR<0.001; n=22) 
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Figure 3 
 
 
 
 
Figure 3. Regions of reduced cerebral blood flow in the hydrocortisone versus placebo 
condition during trauma script presentation in all participants (PTSD and TEC groups, 
cluster-wise FDR<0.001; n=22) 
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Figure 4 
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Figure 4. Mean (SD) cortisol levels (nmol/L) following glucocorticoid versus placebo 
administration over time in PTSD and Trauma-exposed control (TEC) groups 
Note: T1 = baseline, T2 = pre-scan (1 hour after baseline), T3 = post-scan (2 hours after baseline 
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